81 results
8-K
EX-2.2
SURF
Surface Oncology, Inc.
8 Sep 23
Coherus Completes Surface Oncology Acquisition
9:21am
and Stock Payment.
4.8
Audit Rights.
Until one year after the end of the CVR Term (the “Review Request Deadline”), upon the written request … of the Acting Holders (such requesting Acting Holders, the “Audit Rights Acting Holders”) provided to Parent not less than thirty (30) days in advance
DEFM14A
guxt7t9e
26 Jul 23
Proxy related to merger
4:56pm
8-K
EX-99.2
by17fy
3 Jul 23
Report of Independent Registered Public Accounting Firm
4:01pm
8-K
EX-99.1
vv00m1 22m
3 Jul 23
Report of Independent Registered Public Accounting Firm
4:01pm
425
q7atc38awzgzk2q
16 Jun 23
Business combination disclosure
8:08am
8-K
EX-2.1
khyf5nnx9er
16 Jun 23
Coherus to Acquire Surface Oncology
7:45am
425
xrwo5a3x9q jyf9wxb0
16 Jun 23
Business combination disclosure
7:09am
10-K/A
g6axer 8ltg4
1 May 23
Annual report (amended)
4:31pm